TH302在MCF-7和PC-3肿瘤模型中的抑瘤作用
IJC
International Journal of Cancer
Activityofthehypoxia-activatedpro-drugTH-302inhypoxicandperivascularregionsofsolidtumorsanditspotentialtoenhancetherapeuticeffectsofchemotherapy
JasdeepK.Saggar1andIanF.Tannock1,2*
12
DepartmentofMedicalBiophysics,UniversityofToronto,Toronto,ON,Canada
DivisionofMedicalOncologyandHematology,PrincessMargaretCancerCentre,Toronto,ON,Canada
Manychemotherapydrugshavepoortherapeuticactivityinregionsdistantfromtumorbloodvesselsbecauseofpoortissuepenetrationandlowcytotoxicactivityagainstslowly-proliferatingcells.Thehypoxia-activatedpro-drugTH-302mayhaveselectivetoxicityforhypoxicandneighboringcellsintumors.HerewecharacterizethespatialdistributionandabilityofTH-302toselectivelytargethypoxicregionsandcomplementtheeffectofdoxorubicinanddocetaxelbymodifyingbiomarkerdis-tribution.AthymicnudemicebearinghumanbreastMCF-7orprostatePC-3tumorsweretreatedwithdoxorubicinordocetaxelrespectivelyandTH-302aloneorincombination.BiomarkersofdrugeffectincludingcH2aX(amarkerofDNAdamage),
cleavedcaspase-3or-6(markersofapoptosis)andreductioninKi-67(amarkerofcellproliferation)werequantifiedintumorsectionsinrelationtofunctionalbloodvessels(recognizedbyDiOC7)andhypoxia(recognizedbyEF5)usingimmunohisto-chemistry.cH2aXexpressionat10minandcleavedcaspase-3or-6at24hrafterdoxorubicinordocetaxeldecreasedwithincreasingdistancefromtumorbloodvessels,withminimalexpressioninhypoxicregions;maximumreductioninKi67levelswasobservedinregionsclosesttovasculatureat24hr.TH-302inducedmaximalcelldamageinhypoxicandneighboringregions,butwasalsoactiveintumorregionsclosertobloodvessels.TH-302given4hrbeforedoxorubicinordocetaxelincreasedDNAdamageandapoptosisthroughoutthetumorcomparedtochemotherapyalone.Whengivenwithdoxorubicinordocetaxel,TH-302complementsandenhancesanticancereffectsinbothperivascularandhypoxicregionsbutalsoincreasestoxicity.
CancerTherapy
Mostsolidtumorscontainhypoxicregions,andhypoxiccellsmaybeimportantinlimitingtheeffectsofbothradiotherapyandchemotherapy.Thepresenceofoxygenincreasestheeffectsofradiationviaincreased xationoffreeradicalsonDNAstrandsandhypoxiccellsarerelativelyradio-resist-ant.1,2Hypoxiccellsintumorsarede cientinothernutrientsandareslowlyornon-proliferating:theymaybesparedbychemotherapybecauseofpoorpenetrationofdrugstohypoxictumorregions,3andbecausemostanticancerdrugsaremoreeffectiveagainstrapidlyproliferatingcells.Inaddi-Keywords:drugdistribution,pharmacodynamicmarkers,tumormicroenvironment,drugpenetration,hypoxia-activatedpro-drug,TH-302
*Dr.IanF.TannockhasreceivedresearchfundingfromThresholdPharmaceuticals.
Grantsponsor:CanadianInstitutesofHealthResearch(CIHR)andThresholdPharmaceuticalstoDr.TannockandaCIHRBanting&Bestdoctoralstudentship(toJ.K.S.)DOI:10.1002/ijc.28595
History:Received22Aug2013;Accepted25Oct2013;Online8Nov2013
Correspondenceto:IanF.Tannock,PrincessMargaretCancerCentre,Suite5-208,610UniversityAvenue,Toronto,OntarioM5G2M9,Canada,Tel.:1416-946-2245,Fax:1416-946-4563,E-mail:ian.tannock@uhn.cationtotheirradio-resistance,thepresenceofhypoxialeadstoamoreaggressivephenotypeduetotheexpressionofpro-survivalgenes(includingmutatedp53),increasedlevelsofproteinsfavoringanepithelial-to-mesenchymaltransition,increasedmetastasis,angiogenesisandinhibitionofapopto-sis.4Forthesereasons,hypoxiccellsmaybeanimportantcauseoftreatmentfailureinsolidtumorsandmayrepopu-latethetumor.Therapiesthattargethypoxictumorcellsthereforehavepotentialtoaugmenttheeffectsofradiother-apyandchemotherapy.1Also,hypoxiccellsoccurrarelyinnormaltissues,sothattargetingthemmightoffertumorselectivity.Hypoxia-targetedtherapiessuchasgenetherapy(usingapromoterhighlyresponsivetoHypoxiaInducibleFactor-1[HIF-1]),recombinantanaerobicbacteria(whosesporesactivateinnecroticcentersoftumorsandkilltumortissue)andhypoxia-activatedpro-drugs(HAPs)areallunderinvestigation.1,5
HAPsareadministeredinaninactiveformandarereducedtotheiractivemetaboliteswithinhypoxicregionsoftumors.1Onceactivatedtheymaydiffusetoactagainstcellsinneighboringtumorregions(“thebystandereffect”).The rstHAPtoundergoclinicaltestingwastirapazamine;andalthoughactivityagainsthypoxiccellsinhumantumorscouldbeshown,6largerandomizedtrialsevaluatingtirapaz-amineincombinationwithradiotherapyorchemotherapydidnotestablishtherapeuticbene t.7–9Tirapazaminehad
C2013UICCInt.J.Cancer:134,2726–2734(2014)V
Sublethal Irradiation Promotes Migration and Invasiveness of Prostate Cancer PC-3 Cells:Implica_专业资料。维普资讯 http://www.cqvip.com Chns ouna fClclco ...
(MCF-7, Hs-578T) and a human prostate cancer cell line (PC-3) were...mesenchymal transition in human micrometastatic and primary breast carcinoma ...
The multikinase inhibitor sorafenib induces caspase-dependent apoptosis in PC-3 prostate cancer_专业资料。Asa orafdooy(001:2-3 inJunlAnrlg21)25754o@2 ASIM...
Dietary Daidzein Enhances Antiapoptotic Effect of 17β-Estradiol (E2) on Breast Cancer MCF-7 C_专业资料。1 0 Ci acre21:01,00hnCne s()1—621 JR2...
ERK Carcinoma of the prostate is the most common cancer among American men... androgen-insensitive prostate cancer PC-3 cells and human embryonic kidney ...
human prostate cancer DU145 cells, which are ...Pc 4-PDT-treated cells, MCF-7v and MCF-7c3 ...(adherent human breast carcinoma vs. murine ...
Materials and methods Cell culture MCF-7 (human ...(human prostate cancer), PC-3 (human prostate ...and aggressiveness of breast carcinoma cells [8]....
? Human metastatic breast cancer cell line Express high level of mir-21 Human prostate carcinoma PC-3-derived subline PC-3MM cell line : ? MCF-7 ...
For example, this compound inhibits human breast (MCF-7), colon (HT-29), ovarian (A2780), and prostate (DU145, PC-3) cancer4 and B-chronic ...
10) at least in human MCF-7 breast and PC-3 prostate carcinoma cells. ...gov/), with convincing in vivo data obtained in several mouse cancer ...
热门文档